Results 111 to 120 of about 168,705 (262)

Expectations and Reality: The Lived Experiences of Australians With Psychosocial Disability Within the NDIS

Australian Journal of Social Issues, EarlyView.
ABSTRACT While Australia's National Disability Insurance Scheme (NDIS) was founded on principles of choice and control, for people with significant mental health challenges (what the NDIS calls ‘psychosocial disability’) these ideals often remain elusive. Support systems continue to be fractured and in the context of ongoing policy reforms, it is vital
Joel Hollier, Jennifer Smith‐Merry
wiley   +1 more source

Barriers and Enablers for Effective Support Coordination in the National Disability Insurance Scheme

Australian Journal of Social Issues, EarlyView.
ABSTRACT Support coordinators act as intermediaries between the National Disability Insurance Scheme (NDIS) and participants, facilitating access to funded supports. To optimise outcomes, they must navigate NDIS complexities, identify services that meet individual needs and engage with diverse stakeholders.
Sharyn McDonald, Lee Cubis, Di Winkler, Jacinta Douglas   +3 more
wiley   +1 more source

Has Inequity Faced by Young Australians With Disability Changed Since the Turn of the Century?

Australian Journal of Social Issues, EarlyView.
ABSTRACT Despite the introduction of various policies aimed at promoting equality for people with disability since Australia ratified the Convention on the Rights of People with Disabilities (CRPD) in 2008, there has been little evaluation regarding the extent of change in inequity since then.
Asha Parkinson, Joanne Arciuli, Eric Emerson, Sally Robinson, Sally Chance, Gerry Redmond   +5 more
wiley   +1 more source

Sociodemographic Factors Associated with Hours Worked by Primary Carers in Australia

Australian Journal of Social Issues, EarlyView.
ABSTRACT Primary caregivers constitute a major unpaid workforce in Australia. The aim of this study was to determine the sociodemographic factors that are associated with carer workloads. Multinomial logistic regression modelling was applied to the nation‐wide Australian Government survey.
Andrew J. Hamilton
wiley   +1 more source

Insurance coverage and provision of opioid disorder treatment: Evidence from Medicare. [PDF]

J Policy Anal Manage
Agniel D, Cantor J, Maclean JC, Taylor EA, Simon K.   +4 more
europepmc   +1 more source

Stem cell–based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection

Animal Models and Experimental Medicine, EarlyView.
Directed differentiation of pluripotent stem cells into functional pancreatic β cells have emerged as a promising strategy for the radical treatment of type 1 diabetes, with preclinical and early clinical evidence demonstrating reversal of hyperglycemia and insulin independence.
Zifan Li, Yu Kang, Yuyu Niu
wiley   +1 more source

Using prescription drug data for timely assessments of state insurance coverage rates: a validation study. [PDF]

Health Aff Sch
Rome BN, McIntyre A, Kim J, Han J, Kesselheim AS, Sommers BD.   +5 more
europepmc   +1 more source

Prophylactic Enoxaparin Reduces Symptomatic Venous Thromboembolism Compared With No Chemoprophylaxis Within 95 Days After Knee Arthroscopy

Arthroscopy, EarlyView.
Purpose To investigate whether prophylactic use of low‐molecular‐weight heparin (enoxaparin) after knee arthroscopy reduces the incidence of symptomatic venous thromboembolism (VTE) compared with no postoperative pharmacological prophylaxis. Methods We conducted a population‐based cohort study using linked national insurance and hospital data from ...
Aylin Albrecht, Lorenz Kapral, Felix Gruber, Christoph Dibiasi, Oliver Kimberger, Christian Albrecht   +5 more
wiley   +1 more source

Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans

Arthritis &Rheumatology, EarlyView.
Objective We examine coverage of self‐administered disease‐modifying antirheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022–2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T cell costimulatory modulator, interleukin‐6 (IL ...
Youngmin Kwon, Robert W. Corty, Stacie B. Dusetzina   +2 more
wiley   +1 more source

Strategic Delay and Bargaining Over Public Insurance Coverage for Drugs in Australia. [PDF]

Health Econ
Li JJ, Harris A.
europepmc   +1 more source